Clinical trial
Effects of Super 13 Pro & Prebiotics on the Human Intestinal Microflora: a Double-blind, Randomized, Placebo-controlled Study
NCT04043000 is registered in ClinicalTrials.gov with Cheng-Hsin General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Super 13 Pro & Prebiotics on the Human Intestinal Microflora: a Double-blind, Randomized, Placebo-controlled Study
- Lead sponsor
- Cheng-Hsin General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 21, 2019
- Completion date
- November 18, 2019
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prebiotics, probiotics